{"name":"GL Pharm Tech Corporation","slug":"gl-pharm-tech-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oxycontine CR 10mg","genericName":"Oxycontine CR 10mg","slug":"oxycontine-cr-10mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Oxycontine CR 10mg","genericName":"Oxycontine CR 10mg","slug":"oxycontine-cr-10mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5fakljWXI5QzYtQWh2eVB0RG1GaFhrRUhwNFNTWGRValcxcnZpak5xRmo5dEpyODhjeHJCLWlMYVpwUHB2bER1T3dzc2dKb2owb1FkaE1WLXpTWnczeS1XU1EwYUFfSG5oUGk2WENpM0JSU2tKTlU1cDJ3LVI?oc=5","date":"2025-12-12","type":"deal","source":"holdings.toppan.com","summary":"TOPPAN Holdings Acquires Asahi Kasei’s Patented Brittle Lidding Material Technology for Push-through Blister Packs - holdings.toppan.com","headline":"TOPPAN Holdings Acquires Asahi Kasei’s Patented Brittle Lidding Material Technology for Push-through Blister Packs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOUDd1RlhSbVVTZDQ1RGhQUm51enE0dThQelQxbDZZd0hheVZtM3c2TVEtWmJILXV1N2VjUVVXdkdIcjNYQ1FURGRkMjJwbHNvTDBwZzZNb3NOQUVNU3VVM0VlM0RFUktTbTJaUUFCUkdGVUxDTDhEZ194NFpZY0hhYlRJUHRkM243RE5pejAyX3ZjYjF3eDBpX0Y4Tjh5NFQwMUxtY2V3?oc=5","date":"2025-09-22","type":"deal","source":"Pharmaceutical Technology","summary":"Pfizer buys monthly GLP-1RA developer Metsera for $4.9bn - Pharmaceutical Technology","headline":"Pfizer buys monthly GLP-1RA developer Metsera for $4.9bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1RUEo3UklYcHQ2VEhBVEhQaExxNEtaT2RrMGMxZWNPdE1pUndpLTlLbTJaOTdKNFV1RGRLMjg4OTh2N1p1bHp4c1phNG04ZkpwZkFlSjR2WHRGSjFUOGxZZWwtOTVuWGtkc19GQ3NR?oc=5","date":"2025-07-04","type":"pipeline","source":"팜이데일리","summary":"Rokit Healthcare Surges on AI Skin Cancer Regeneration Breakthrough[K-bio Pulse] - 팜이데일리","headline":"Rokit Healthcare Surges on AI Skin Cancer Regeneration Breakthrough[K-bio Pulse] - 팜이데일리","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNcWVZUy1YZ3REUGJMN3JwOFFDbng1UVk2a2xfTmhfRklSQmNyMjZkaWdDRHUteUd0WXV0T3Axdmthdkk5MHRzOWl4OXdvS0lGZU1YZGRheFVyWWJvTmFCSVRDQ1A1RDBKVEpadXd3OHVnR19lMFJNYTR4Tmp3QWxycmJza2JsZGFaOXQta3JlMUprTzZuUE9Td0dfZDQ?oc=5","date":"2025-04-29","type":"pipeline","source":"HackerNoon","summary":"Selvaraja Elumalai's Digital Evolution at a Leading Pharmaceutical Company - HackerNoon","headline":"Selvaraja Elumalai's Digital Evolution at a Leading Pharmaceutical Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBmTXBxQjdXMC03a1Z3aG9QclhOc3lpMW9pbHBRR1Vwd2FISlNVVC1Jcmt6QlRVLTM1cmQtWkFIRlhxLWZGR0RKaFdHWXBWaHE4cW5CYW91SmNQTXpPekU2TTVHcE56MVZhSWxoVWdB0gFyQVVfeXFMTnVwYXFOTGtkb3BEN28xS19KaGNBbDVhc3JVWk1HdnlCNkRyYThOb1pjV3FDQW40VXFUelRjLU5ZaDlqa3BldEFYZE5fbzkydUFVMVB5UFF5aDR5MzJFUzIxZnBoNUx6UzNWaHJjTklhbVFR?oc=5","date":"2025-04-23","type":"trial","source":"koreabiomed.com","summary":"Aju Pharm successfully completes phase 3 trial of dry eye drug - koreabiomed.com","headline":"Aju Pharm successfully completes phase 3 trial of dry eye drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1xM2JBTEhZQnR1MkNEMEx5THZSNDYtWmtLV3Y3RWZEQUZ4eV9PRi1TbWZZZDNtR01hbk43dEFnOTBBRXo4ZmstUTliRHZRWlQzcXRhR2tZWHJRWXpYT3dmUEktS1RSMDlsendDWVhR0gFyQVVfeXFMTjVCWEI0cF9TTU54UTZqc1VpYnIwU1VaSVg5UnFacWQtcWR2dHVoemo5cllWQXQ1bV9LMzhkOFdrZXplQV92STBPNkJQbmw0bWpiUDZWZ285ZEtwZThtdGRRTnBLRURUWFVVUGJZNXhjcmVB?oc=5","date":"2024-09-04","type":"deal","source":"koreabiomed.com","summary":"GL PharmTech signs deal to export sex hormone drug to Philippines - koreabiomed.com","headline":"GL PharmTech signs deal to export sex hormone drug to Philippines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOUUx4SEdneDFmTkg5YlJiLXRmbGdmX3dHX1c2MnZXc2dVLWdEUVlGX1NINDA3ZS1WVzBzeVdFdUw2TDJhaURnbmhUZElTVkhQMFE1M05GZjlyZmJCSkFiN0xDYTNHbmhMUEJ4dEVvVDloczd1eWhlSXIzQ1ZHenJ2bmNXeGZoeEJ5WWZfWkZtb3lMUlEta2p3NA?oc=5","date":"2023-10-15","type":"pipeline","source":"C&EN","summary":"Private equity ramps up in pharmaceutical services - C&EN","headline":"Private equity ramps up in pharmaceutical services - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOcDF4dzd5dkkyMk9MTzdQTC1nYXpOUXMtY2tZaHd2NFlIVXVVdU5KZjlHXzhORDIzYm14U0htS0VHMHpiMnBRMDZhN1VZZ1NrMXczQW5NcFAwRTBldlVTMmNGZDEzdUQ3S1l6WkgwM3htZ2g3N2dveHJrVGpMMC1RSFpHa0hFTVRNckJwWkFlWHUxTnhZS3ljbVZsV08xZU5JTkJVQi1jeVfSAa4BQVVfeXFMTUZ4YkRudWM4dzlUejZCem9ldEtXLU9rYzFDeVhXb2xMaGJxS0NDOEVNQTJRcTlBVWpxbUZsajVBQ1VDam9kYmxBSk5aWXFkN0V0dWJncllQYmNOMlRnLUNOZ0NJdzJkOVVmVnpnYVhuZFNsV013Y0xoc2lKZkxrMWVqVHhwRVh6eDVmREpvWVlnVmczWE45NE9HSl9vVHg1RkI5Q0IyTWVRQnlDNkZR?oc=5","date":"2023-09-14","type":"pipeline","source":"The Korea Times","summary":"GL Pharm Tech to raise $6.9 mil. via stock offering - The Korea Times","headline":"GL Pharm Tech to raise $6.9 mil. via stock offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNWGhQNjA5Wm93TkswclFRNVhkS2ItbXN5SnFWUUx4U0d4TEFEek1qYS1jUFRJTmhpVlBJVWdpVklDTHFzbTJwcGgzUk54ZjlfeXpYbXY5NnpDUGZNSnU2VmhhcU1QMlFBMkJocS04YXJHTm5VYlQwMGxmV0JRYTg0R1FoODhrSjA1Ymg0em9naU95YjVpX2c0eEZMaEoxR2JzdlJnc0Q1Sk1KRWNFYnBZTHhPYmNkQ0k?oc=5","date":"2023-04-21","type":"pipeline","source":"Business Wire","summary":"GL CHEMTEC Announces Formation of Scientific Advisory Board - Business Wire","headline":"GL CHEMTEC Announces Formation of Scientific Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPNUlDc0xZa2pXaDVaRU5zaGt0RW1YMkM5M3VkRDhrTVBfQS11b185VHNRUFBfZnF2bDVKenVuRTVTdkhDaGtISlIzMEpJcC1UM2xlY2hlSHNuR00wTDJjQm56NHNwLWJrdndSZG9iNGM0NGVhUW1YTDZhLW9uZmlxSmVHLWppQkd0Tm91aGpQSWxzT1MzQ05ieVI2VFFkV056MjQzNXFzOXA3YnJmbU92TThn?oc=5","date":"2022-07-14","type":"pipeline","source":"ey.com","summary":"CDMOs are becoming emerging technology leaders - ey.com","headline":"CDMOs are becoming emerging technology leaders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQMlItdUNIVXlfZ1I1VkNTVUJJTm1HbW5uQ0ozdjJBQlJaLUI2cnVGMi13RHp1Zzc5dXM5SldmV0g4WDNzSHljaG5ibGswUThHOGVvdVRHTFdnTmlSOThPNFBWamJLRzE0bERQLS1hWW9WODF6VXpUaXpDNVY5dzZuRUFVMWpiZjdhSmdva1B5SXM?oc=5","date":"2020-08-04","type":"pipeline","source":"PharmTech.com","summary":"Cleaning Limits—Why the 10-ppm Criterion should be Abandoned - PharmTech.com","headline":"Cleaning Limits—Why the 10-ppm Criterion should be Abandoned","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiOkFVX3lxTE9xUnktMklHVURZci1jbkxlOUlJWXAwd0JFLXItcENtRDJlM3dINVJVZkV0S3BmeFVwcGc?oc=5","date":"2006-03-15","type":"pipeline","source":"Merck.com","summary":"Merck | Home - Merck.com","headline":"Merck | Home","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}